COMBINED ENZYME-REPLACEMENT AND SUBSTRATE-REDUCTION THERAPIES IN GAUCHER DISEASE TYPE II/III

被引：0
|
作者：
Gautschi, M. [1 ]
Nava, E. [2 ]
Simonetti, Goeggel B. [2 ]
Nuoffer, J. M. [3 ]
机构：
[1] Univ Child Hosp, Interdiscipl Metab Unit, Bern, Switzerland
[2] Univ Child Hosp, Neuropediat Unit, Bern, Switzerland
[3] Univ Hosp Bern, Inst Clin Chem, CH-3010 Bern, Switzerland
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [31] Pulmonary involvement in patient with Gaucher disease type III after 4 years of enzyme replacement therapy
    Djordjevic, M.
    Minic, P.
    Djuricic, S.
    Djokic, D.
    Sarajlija, A.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 119 - 119
  • [32] The effect of enzyme therapy in a patient with Gaucher disease type III
    Bosman, DK
    Hollak, CEM
    Aerts, JMFG
    Bakker, HD
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1996, 19 (05) : 703 - 704
  • [33] Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
    Lee, Ni-Chung
    Chien, Yin-Hsiu
    Wang, Chung-Hsing
    Wong, Siew-Lee
    Peng, Steven Shinn-Forng
    Tsai, Fuu-Jen
    Hwu, Wuh-Liang
    [J]. MOLECULAR GENETICS AND METABOLISM REPORTS, 2022, 31
  • [34] Enzyme replacement therapy in type 1 Gaucher disease and a review of the literature
    Kabacam, Gokhan
    Kabacam, Gulsah
    Topcuoglu, Pervin
    Kuzu, Isinsu
    Arat, Mutlu
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2010, 27 (03) : 190 - 195
  • [35] Enzyme replacement therapy in adult patients with type I Gaucher disease
    Ponomarev, R., V
    Lukina, E. A.
    [J]. TERAPEVTICHESKII ARKHIV, 2019, 91 (07): : 127 - 131
  • [36] A prospective study of enzyme replacement therapy in type 3 Gaucher disease
    Schiffmann, R
    Parker, CC
    Scott, LJC
    DeGraba, T
    Brady, RO
    Barton, NW
    [J]. NEUROLOGY, 1996, 46 (02) : 1107 - 1107
  • [37] Enzyme replacement therapy in romanian patients with type 1 Gaucher disease
    Sido, P. Grigorescu
    Drugan, C.
    Cret, V.
    Al-Kzouz, C.
    Denes, C.
    Zimmermann, A.
    Coldea, C.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 : S118 - S118
  • [38] Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease
    Di Natale, Paola
    Villani, Guglielmo R. D.
    Parini, Rossella
    Scarpa, Maurizio
    Parenti, Giancarlo
    Pontarelli, Gianfranco
    Grosso, Michela
    Sersale, Giovanna
    Tomanin, Rosella
    Sibilio, Michelina
    Barone, Rita
    Fiumara, Agata
    [J]. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2008, 49 (3-4) : 219 - 223
  • [39] Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy
    Langeveld, A.
    de Fost, M.
    Aerts, J. M. F. G.
    Sauerwein, H. P.
    Hollak, C. E. M.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2008, 40 (03) : 428 - 432
  • [40] Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: Two case reports
    Amato D.
    Patterson M.A.
    [J]. Journal of Medical Case Reports, 12 (1)
12345